Understanding how people access and use naloxone for overdose prevention
Official title: A National Survey on Naloxone Use and Access
Funded at Rand Corporation · NIH-10923463 · Data updated 2026-11-12
This study is looking at how easy it is for people to get and use naloxone, a lifesaving medicine that can reverse opioid overdoses, by asking questions about who carries it, where they get it, and any challenges they face, so we can help make it more available and affordable for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $424,545 |
| NIH project number | 1R21DA060711-01 |
| Project ID | NIH-10923463 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who are at risk of opioid overdose or those who know someone at risk, as well as healthcare providers involved in naloxone distribution.
✕Less likely to help
Patients who do not use or are not at risk of opioid medications may not benefit from this research.
What this research studies
This research investigates the accessibility and usage of naloxone, a medication used to reverse opioid overdoses, among the general public. It aims to identify how many people carry naloxone, where they obtain it, and the barriers they face in accessing it. The study will involve surveys and vignettes to gather data on purchasing behaviors and optimal pricing for naloxone, especially as new over-the-counter options become available. By monitoring these factors, the research seeks to provide insights that can inform policies to improve naloxone distribution and affordability.
Why it matters
Potential benefit: If successful, this research could lead to improved access to naloxone, potentially saving lives by reducing overdose deaths.
How similar studies have gone: Previous research has shown that improving naloxone access among laypersons can effectively reduce overdose deaths, indicating that this approach has potential for success.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Powell, David — Rand Corporation
- Study coordinator: Powell, David
Related research
Other NIH-funded projects on the same topics.
-
Incentives and Anchoring to Improve Long-term HIV Medication Adherence
A study tests a simple, daily habit plan combined with friendly reminders and small rewards to help people living with HIV take their ART pills on time.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
-
Game Changers for cervical cancer prevention in Uganda
A community-based program helps women who have been screened share knowledge to encourage more women to get screened for cervical cancer in Uganda.
-
Game Changers for Cervical Cancer Prevention in Uganda
A program using peer-led group sessions in Uganda aims to help more women get screened for cervical cancer using a low-cost method.
-
Partnering to Build Native American Research Capacity in HEAL Topics
Aimed at helping Tribes and Native American Serving Organizations grow their own NIH-funded research capacity around HEAL topics.
-
Evidence-based alcohol and sexual risk support in homeless young adults
A real-world study will bring a proven counseling approach to drop-in centers serving 18–25-year-olds who are homeless, to help reduce alcohol use and risky sexual behaviors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.